Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
5 trials
Recent
Start date
Enrollment
Phase 2
×
Has announcements
×
Breast Neoplasms
×
Clear all
Filters
3
NCT02568267
2026-03-06
STARTRK-2
Hoffmann-La Roche
Phase 2
Active not recruiting
534 enrolled
1 FDA
NCT02576431
2025-11-12
NAVIGATE
Bayer
Phase 2
Completed
215 enrolled
3 FDA
NCT03248492
2025-06-26
DESTINY-Breast01
Daiichi Sankyo
Phase 2
Terminated
253 enrolled
21 charts
1 FDA
NCT02614794
2023-08-14
HER2CLIMB
Seagen Inc.
Phase 2
Completed
612 enrolled
30 charts
2 FDA
NCT02102490
2020-01-21
MONARCH 1
Eli Lilly and Company
Phase 2
Completed
132 enrolled
17 charts
1 FDA